[Sjogren's syndrome].
Naumann
U Kolyvanos
UK
Medizinische Poliklinik Universitätsspital Zürich, Zürich. urania.kolyvanos@usz.ch
Käser
L
L
Vetter
W
W
D000367:Age Factors; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018721:Muscarinic Agonists / Q000627:therapeutic use; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D011379:Prognosis; D012464:Saliva, Artificial / Q000627:therapeutic use; D012737:Sex Factors; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy
D018721:Muscarinic Agonists; D009883:Ophthalmic Solutions; D012464:Saliva, Artificial; D010862:Pilocarpine